We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$557M
AUM Growth
+$8.06M
Cap. Flow
-$17.4M
Cap. Flow %
-3.12%
Top 10 Hldgs %
15.98%
Holding
514
New
65
Increased
139
Reduced
63
Closed
62

Top Buys

Rank Stock Value
1
OVID icon
Ovid Therapeutics
OVID
+$3.98M
2
AMRX icon
Amneal Pharmaceuticals
AMRX
+$2.56M
3
SIGA icon
SIGA Technologies
SIGA
+$2.52M
4
III icon
Information Services Group
III
+$1.69M
5
RVI
Retail Value Inc. Common Shares
RVI
+$1.67M

Top Sells

Rank Stock Value
1
ACH
Accendra Health
ACH
+$5.72M
2
UCTT
Ultra Clean Holdings
UCTT
+$2.82M
3
MITK icon
Mitek Systems
MITK
+$2.11M
4
BLDR icon
Builders FirstSource
BLDR
+$2.1M
5
MEDP icon
Medpace
MEDP
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.86%
2 Industrials 16.1%
3 Technology 15.87%
4 Financials 14.48%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATSG
501
DELISTED
Air Transport Services Group
ATSG
– –
-54,206
Closed -$1.59M
PRFT
502
DELISTED
Perficient Inc
PRFT
– –
-32,100
Closed -$1.89M
BFX
503
DELISTED
BowFlex Inc.
BFX
– –
-45,760
Closed -$716K
AVTA
504
DELISTED
Avantax, Inc. Common Stock
AVTA
– –
-31,521
Closed -$525K
KBAL
505
DELISTED
Kimball International
KBAL
– –
-51,920
Closed -$727K
RNDB
506
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
– –
-9,664
Closed -$193K
NPTN
507
DELISTED
NEOPHOTONICS CORP
NPTN
– –
-73,964
Closed -$884K
EBSB
508
DELISTED
Meridian Bancorp, Inc.
EBSB
– –
-14,943
Closed -$275K
XEC
509
DELISTED
CIMAREX ENERGY CO
XEC
– –
-18,193
Closed -$1.08M
SNR
510
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
– –
-264,446
Closed -$1.65M
SYKE
511
DELISTED
SYKES Enterprises Inc
SYKE
– –
-19,556
Closed -$862K
VER
512
DELISTED
VEREIT, Inc.
VER
– –
-9,020
Closed -$348K
FBC
513
DELISTED
Flagstar Bancorp, Inc. New
FBC
– –
-17,720
Closed -$799K
AZPN
514
DELISTED
ASPEN TECHNOLOGY INC
AZPN
– –
-914
Closed -$132K
17 18 19 20
21

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Globeflex Capital held 514 positions worth $557M, up 1.5% from $549M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Globeflex Capital withdrew a net $17.4M in Q2 2021, closing 62 positions and reducing 63 holdings. Its most notable exit was Perficient Inc, an estimated $1.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Globeflex Capital opened a new position in Ovid Therapeutics worth $3.95M.

  • Globeflex Capital's largest Q2 2021 buy was Ovid Therapeutics: 1,009,125 shares worth $3.95M.
  • Globeflex Capital added most to Amneal Pharmaceuticals in Q2 2021, an estimated $2.56M increase.
  • Globeflex Capital's biggest Q2 2021 reduction was Accendra Health, cutting an estimated $5.72M.
  • Globeflex Capital fully exited Perficient Inc in Q2 2021, selling an estimated $1.89M.
  • Globeflex Capital's ten largest holdings make up 16% of its $557M portfolio in Q2 2021.
  • Globeflex Capital opened 65 new positions and closed 62 in Q2 2021.
  • Globeflex Capital's portfolio value rose 1.5% quarter-over-quarter to $557M.

Based on Globeflex Capital's 13F filing for Q2 2021, filed 12 Aug 2021.